跳至主要内容
临床试验/NCT05323370
NCT05323370已完成不适用

Study of New Potential Biomarkers of Lymphangioleiomyomatosis: Determination of Cathepsin K, Cystatin C, Collagen Telopeptides and Chondroitin Sulfates

University Hospital, Tours1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2022年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
urine cathepsin K proteins levels

研究概览

简要总结

This is a physiopathological case-control, non-interventional, monocentric study of adult patients with lymphangioleiomyomatosis. The controls are patients followed in neurology at the CHU of Tours for a tuberous sclerosis complex without lymphangioleiomyomatosis, the healthy volunteers are women with neither pulmonary nor renal pathology and recruited at the clinical investigation centre of the CHU of Tours.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

urine cathepsin K proteins levels

时间窗: inclusion visit

comparison of urine cathepsin K protein levels in the 3 groups

urine cathepsin K activity

时间窗: inclusion visit

comparison of urine cathepsin K activity in the 3 groups

次要结局

  • urinary quantity of cystatin C(inclusion visit)
  • FEV1 measurement(inclusion visit)
  • serum level of chondroitin sulphates(inclusion visit)
  • urinary quantity C and N-telopeptides of type 1 collagen(inclusion visit)
  • VEGF-D measurement(inclusion visit)
  • T-score measurement(inclusion visit)
  • renal angiolipomas(inclusion visit)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验